-
Mashup Score: 0Sintilimab With Chemoradiotherapy Improved Event-Free Survival for Patients With High-Risk Nasopharyngeal Carcinoma - 8 month(s) ago
Jun Ma, MD, discusses results of a phase 3 trial which evaluated the addition of sintilimab to induction chemotherapy and concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma.
Source: www.hmpgloballearningnetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Treatment patterns and survival in older adults with unresected nonmetastatic biliary tract cancers - 1 year(s) ago
The optimal treatment for unresected nonmetastatic biliary tract cancer (uBTC) is not well-established. The objective of this study was to analyze the treatment patterns and compare the differences in overall survival (OS) between different treatment strategies amongst older adults with uBTC.
Source: Journal of Geriatric OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer - 2 year(s) ago
This cohort study describes the incidence of atrial fibrillation in patients with lung cancer and assesses predictive cardiac dosimetric parameters.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer - 2 year(s) ago
This cohort study describes the incidence of atrial fibrillation in patients with lung cancer and assesses predictive cardiac dosimetric parameters.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Source: link.springer.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial - 2 year(s) ago
The addition of galunisertib to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer improved the complete response rate to 32%, was well tolerated, and warrants further assessment in randomised trials.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial - 2 year(s) ago
The addition of galunisertib to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer improved the complete response rate to 32%, was well tolerated, and warrants further assessment in randomised trials.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer – Full Text View.
Source: clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
In an interview with Oncology Learning Network, Jun Ma, MD, discussed results of the phase 3, randomized controlled CONTINUUM trial. Learn more here: https://t.co/XaRe2ega8x #onctwitter #medtwitter #sintilimab #chemoradiotherapy #NasopharyngealCarcinoma https://t.co/tOqC6GJSSM